Publicerad: 2022-04-21 15:58 | Uppdaterad: 2022-04-21 16:09

Aktuella utlysningar, vecka 16, 2022

Grants Office tipsar om aktuella anslag


Svenska och nordiska anslag

 

Hjärt-Lungfonden
 

Projektbidrag

Hjärt- Lungfonden ger stöd till forskningsprojekt inom fondens områden. Projekt kan pågå i mellan ett och tre år.
 

Forskartjänster

Hjärt-Lungfonden ger stöd till ett begränsat antal fleråriga forskartjänster. Tjänsterna är främst avsedda som karriärutvecklingstjänster för yngre forskare vilka kan förväntas få ledande vetenskapliga positioner i framtiden. Forskare som söker detta anslag blir även sökande för fondens forskarmånader för disputerade.
 

Forskarmånader

Hjärt-Lungfonden utlyser anslag för forskarmånader för disputerade och doktorander. Dessa syftar till att ge fler forskare möjlighet till forskningstid.
 

Postdoktortjänst

Hjärt-Lungfonden ger från och med 2022 stöd till ett antal fleråriga postdoktortjänster som ska ses som en karriärutvecklingstjänst. Tjänsterna är avsedda för yngre forskare som vill satsa på en akademisk forskningskarriär. För att ge större flexibilitet i beslut om tilldelning av postdoktortjänst och forskarmånader för disputerade så blir den som söker postdoktortjänst även sökande för forskarmånader för disputerade.
 

Postdoktorstipendium utomlands

Hjärt-Lungfonden beviljar ett begränsat antal stipendier för forskning på postdoktornivå vid erkänd utländsk institution.


Återvändarbidrag

Syftet med bidraget är att underlätta fortsatt forskning i Sverige efter postdoktorvistelse vid utländskt universitet. Hjärt-Lungfonden beviljar ett begränsat antal bidrag efter avslutad postdok i utlandet.

Closing date: 18 May 2022

More information 

 

State-of the-Art Immunogen Design using Computational Antigen Simulation Technologies for Vaccine Development Against Emerging Infectious Diseases - Coalition for Epidemic Preparedness Innovations (CEPI)

This Call for Proposal (CfP) asks for submissions for state-of-the art computational immunogen design to develop vaccine candidate platforms against high-risk virus families for the Disease X project. This effort will support the generation of vaccine libraries with the ambition to deliver a vaccine within 100 days of an outbreak from emerging threats. The vision for this CfP is to use integrated machine learning-based programs that integrate computational modelling methods and structural virology for immunogen designs for vaccine candidates.

Closing date: 31 July 2022

More information 

 

Innovative technologies to improve vaccine thermostability - Coalition for Epidemic Preparedness Innovations (CEPI)

The Call for Proposals (CfP) asks for the submission of an Expression of Interest (EoI) for innovations that improve vaccine thermostability for use in outbreaks of known viruses as well as novel or previously unrecognised viruses.

Closing date: The CfP for is open from January 31, 2022, to December 31, 2022. Expressions of Interest may be submitted at any time during the open period and will be reviewed on a quarterly basis. 

More information 

 

RNA vaccine platform technologies and vaccine library development against emerging and select endemic infectious diseases, focus area 2 - Coalition for Epidemic Preparedness Innovations (CEPI)

This Call for Proposal (CfP) asks for the submission of an Expression of Interest (EoI) for RNA platform technologies used for the development of vaccine candidates against a specified list of known pathogens and the development of vaccine libraries against high priority virus families with the potential for Disease X emergence. The CfP is divided into two Focus Areas.

Focus Area 2 seeks novel RNA platform technologies based on potentially high-impact innovations offering substantial advantages over existing mRNA technologies. These advantages may involve attributes such as multivalency, immunogenicity/reactogenicity balance, storage and stability, productivity, response time, and cost-of-goods (COGs). Focus Area 2 provides seed funding for activities including discovery research, preclinical proof-of-concept studies, and limited early clinical proof-of-concept studies.

Closing date: The CfP for Focus Area 2 is open from January 17, 2022 to December 31,2022. EoI for Focus Area 2 may be submitted at any time during the open period, but will be reviewed approximately on a quarterly basis.

More information 

 

Grants for research related projects - Swedish Asthma and Allergy Association

Support various research-related projects, among other things to arrange scientific meetings and lectures in the field of allergy as well as for feasibility studies, degree projects, initiatives for research areas, articles, questionnaires and more.

Closing date: None, applications can be submitted at any time

More information 

 

Novo Nordisk prize

Novo Nordisk Foundation | Novo Nordisk Fonden This recognises an active scientist who has provided outstanding international contributions to advance biomedical research in Europe for the benefit of the public. The prize is worth DKK 5.5 million.

Closing date: 1 Jun 2022

More information

 

Anmäl dig till digitala workshops i populärvetenskapligt skrivande 

Dessa anordnas av den internationella nyhetssajten The Conversation i samarbete med KI:s kommunikationsavdelning.

Anmäl dig via KI:s kommunikationsavdelning på the-conversation@ki.se om du är intresserad av att medverka.

5 maj,10:30-12:30 via Zoom. Workshop: Hitta nyhetspotentialen i din forskning och skriv för The Conversation

23 maj,10:30-12:30 via Zoom. Workshop: Hitta nyhetspotentialen i din forskning och skriv för The Conversation ​​​​​​
 

Europeiska anslag

 

Research fellowships, European Society for Medical Oncology, EUR

The European Society for Medical Oncology invites applications for its research fellowships. These support high-quality research projects in either translational or clinical research. Fellowships may be in the following areas:

•translational – aiming to provide training in translational cancer research in European centres and improve career development through collaboration;

•clinical – aiming to provide training in clinical research in European cancer centres, as well as to support the development of clinical oncology research projects.

Eligibility: Applicants must be members of the society and under the age of 40. They must also be oncologists with at least one year of experience in medical, radiation or surgical oncology and currently engaged in cancer research or clinical oncology practice and be proficient in English.

Budget: Fellowships are worth €40,000 over one year. A second year prolongation is possible for translational research fellowships, including an additional €40,000. The host institutes receive €1,000 to cover administration costs.

Deadline: 15 May 2022

More information

 

Research grants - Childhood Eye Cancer Trust, GB

The Childhood Eye Cancer Trust invites applications for its research grants. These support research on retinoblastoma. Grants may fund the following:

•clinical research into new treatments for retinoblastoma which might improve efficacy, minimise adverse effects and maximise vision, including new molecules, non-chemotherapy treatments, and drug delivery techniques;

•laboratory-based basic science research to improve the understanding of the molecular mechanisms and genetic basis of retinoblastoma, including the study of new cellular pathways and inhibitors;

•psycho-social research on the effects of having retinoblastoma so that ways to reduce the negative impact on those affected can be developed.

Grants are worth up to £50,000 each.

Closing date 13 May 2022

More information 

 

European scientific conference on applied infectious disease epidemiology – funding initiative  - European Centre for Disease Prevention and Control

The European Centre for Disease Prevention and Control invites applications for its funding initiative at the European Scientific conference on Applied Infectious Disease Epidemiology (ESCAIDE). This enables early-career public health professionals without sufficient funds to attend the ESCAIDE conference, to be held from 23 to 25 November 2022 in Stockholm, Sweden.

Individuals who have an accepted abstract for the conference, a maximum of five years work experience, or are a current MSc or PhD student in areas relevant to public health or infectious diseases epidemiology, prevention and control, may apply. Applicants must be either EU or EEA nationals, or have been living in an EU or EEA member state for at least three years with residency and working permit. Staff members of an EU institution are not eligible to apply.

Funding covers travel and accommodation, conference registration and reimbursement of the per-diem for the three days.

Closing date 18 May 2022

More information

 

Ageing well in the digital world – advancing inclusive health and care solutions for ageing well in the new decade collaborative grants -  ERA-Net Active Assisted Living Programme

The ERA-Net Active Assisted Living Programme invites applications for collaborative projects on advancing inclusive health and care solutions for ageing well in the new decade. This supports innovative, translational and multidisciplinary collaborative projects open to all active assisted living application areas, but with a focus on inclusive health and care approach, health and care ecosystems and the accessibility of digital solutions. The following activities are supported

•developing, testing, validating, scaling up and integrating innovative ICT solutions for ageing well into redesigned service delivery models aimed at guaranteeing positive health;

•supporting the public health and care systems, contributing to the creation, strengthening and connection of healthy ageing ecosystems and promoting the development of digital literacy among the end users.

Consortia must include at least three and up to 10 independent eligible organisations from at least three different partner states. Participating countries are: Austria, Belgium, Denmark, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Switzerland and Taiwan. Consortia must include at least one for-profit business partner, one for-profit SME partner and one end-user organisation. The SME partner may be the business partner. Projects may also include associated partners that do not comply with the national eligibility criteria or are based in non-participant countries.

The total budget is worth €5 million. Funding is worth up to €2.5m per project for between 12 and 30 months.

Closing date 21 May 2022 (Forecast)

More information 

 

Coming soon: Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2022

The MSCA 2022 Postdoctoral Fellowships program will open on May 12th after a delay. You can do a postdoc either within Europe with a 2-year fellowship (European Fellowship), or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship.

Closing date: 14September 2022

KI information 

Info about the program

Link to the call

 

Coming soon:  Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks 2022 (former ITN)

The MSCA 2022 Doctoral Networks program will open 12th May, 2022. Principal Investigators participate or coordiantes a Consortium that applies for a training program for PhD students. The PhD students are to be recruited after the project is awarded. The MSCA Doctoral Networks program includes training networks, Industrial Doctorates and Joint Doctorates.

Closing date: 15 November 2022

KI information

Info about the MSCA DN program

Link to the call
 

Amerikanska anslag

 

Federal Funding agencies

 

Alcohol Health Services Research (R01 Clinical Trial Optional), US

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This FOA will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Deadline: June 05, October 05, 2022, and February 05, 2023. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-22-156

More information

 

Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01, R21 Clinical Trial Not Allowed), US

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) is soliciting Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nation’s research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. Applications are welcome in all topics relevant to Down syndrome-related research or its co-occurring conditions. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in research related to Down syndrome.

Deadline: July 01, 2022, July 01, 2023, July 01, 2024. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-OD-22-009 (R01), RFA-OD-22-007 (R21)

More information (R01), (R21)

 

Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed), US

The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis in the CNS. Applicants may propose to investigate biological mechanisms involving exRNA carrier subclasses, or propose to develop improved technologies to investigate extracellular vesicles or other exRNA carriers.

Deadline: October 13, 2022, March 15, 2023. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-20-147

More information 
 

 

Foundations
 

Innovator awards – inflammatory bowel disease, Kenneth Rainin Foundation, US

The Rainin Foundation supports high-risk research and challenges investigators to push boundaries to advance their goal of predicting and preventing Inflammatory Bowel Disease (IBD).

Through the Innovator Awards, the Rainin Foundation invests in new and veteran IBD researchers alike and embrace novel, untested ideas. The funding interests span the spectrum of basic, translational and clinical science.

Earlier funded areas through Innovator Awards include: Bioengineering, Diet and Nutrition, Epithelial Cell/Molecular Biology, Fecal Microbiota Transplant, Immunity and Inflammation, Microbiome, Therapeutic Development and Delivery.
Eligibility:

  • Advanced degree (MD, PhD or the equivalent)
  • Academic position at university, medical center or research institution
  • Innovator Awards may only have one Principal Investigator, and funding is awarded to their home institution. However additional investigators may be included as Co-Investigators, and the lead institution can create subaward(s).
  • Postdocs are not eligible to apply as a Principal Investigator.

Budget: Up to $150,000 USD for one year which may include up to 10% for indirect costs. Recipients who demonstrate significant progress may receive up to two additional years of support.

Deadline: Letters of Inquiry (LOIs) September 30, 2022 by 5PM PST. Full proposals are due by 5PM PST on January 27, 2023. (by invitation only)

More information 

 

Michelson prizes – next generation grants Human Vaccines Project, US

The Human Vaccines Project, with funding from the Michelson Medical Research Foundation, invites initial applications for the Michelson prizes – next generation grants. These support young investigators who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery and immunotherapy research for major global diseases.

Eligibility:

  • Applicants must be 35 or younger at the time of submission.
  • Early career independent investigators, postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are eligible for these awards.
  • Eligible applicants must be employed by, or affiliated with, an eligible organization (e.g., academia, biotechnology companies, foundations, government and non-governmental organizations, and research institutes).

Budget: $150,000 is the full amount of the award. No indirect costs!

Deadline: June 26, 2022

More information 

 

Global research award, American Society of Hematology, US

The American Society of Hematology invites applications for its global research award. This supports haematologists between completion of training and the establishment of their independent careers. The following types of projects are considered:

  • haematology research, including basic, translational, patient-oriented and outcomes-based research;
  • requests for training at other institutions by trainees or early-career investigators, pilot studies, collaborative projects and other proposals for career development.

Eligibility:

  • Individuals with an MD, PhD, MD-PhD or an equivalent degree may apply.
  • Applicants holding an MD should have graduated no more than 16 years prior to application, or have no more than 10 years of postdoctoral experience after graduation.
  • Applicants holding both MD and PhD degrees must be within 16 years of graduation while PhD applicants should have at least one year of experience.
  • They must also be members of the society in good standing.

Budget: Project length may vary from six months to three years depending on the proposed project need. For projects of one year or less, applicants may request up to USD 100,000. For projects of more than one year, applicants may request up to USD 150,000.

Deadline: Letter of Intent August 31, 2022

More information